# Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease

Study · id `cardio:ct-nct00930436` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT00930436](<https://clinicaltrials.gov/study/NCT00930436>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT00930436

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 391 participants.

## Technical summary

Registry record NCT00930436. Randomized; quadruple masking; primary purpose prevention. Start 2010-01 (registry gives no type); primary completion 2012-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 391 participants (enrolled count; ClinicalTrials.gov record NCT00930436, source copy `cardio:ctgov-nct00930436-2012-08-23`, retrieved 2026-10-26)
- Start date: 2010-01 (registry gives no type) (ClinicalTrials.gov record NCT00930436, source copy `cardio:ctgov-nct00930436-2012-08-23`, retrieved 2026-10-26)
- Primary completion: 2012-08 (actual) (ClinicalTrials.gov record NCT00930436, source copy `cardio:ctgov-nct00930436-2012-08-23`, retrieved 2026-10-26)
- Completion: 2012-09 (anticipated) (ClinicalTrials.gov record NCT00930436, source copy `cardio:ctgov-nct00930436-2012-08-23`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT00930436, source copy `cardio:ctgov-nct00930436-2012-08-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct00930436-2012-08-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease
- Acronym: BOSS
- Condition: Contrast Induced Kidney Injury.
- Intervention (Drug): sodium bicarbonate
- Lead sponsor: MD Scientific
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: a15cf6b2f105a1fc4b9c0f189935ae4b20aea90c056465529ae37dd6fe9bd211
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
